Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Working Capital/Sales

    Back to All Ratios
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Working Capital/Sales History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 4.443.842.822.952.81

What is the latest Working Capital/Sales ratio of BAFNA PHARMACEUTICALS ?

The latest Working Capital/Sales ratio of BAFNA PHARMACEUTICALS is 4.44 based on Mar2025 Standalone results.
Year Working Capital/Sales
Mar20254.44
Mar20243.84
Mar20232.82
Mar20222.95
Mar20212.81

How is Working Capital/Sales of BAFNA PHARMACEUTICALS Trending?

Years Working Capital/Sales % Change
Mar2025 4.44
15.63
Mar2024 3.84
36.17
Mar2023 2.82
-4.41
Mar2022 2.95
4.98
Mar2021 2.81 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Working Capital/Sales ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹366.5 Cr -7.7% 37.5% 87.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,791.0 Cr 1.2% 4.2% -10.9% Stock Analytics
DIVIS LABORATORIES ₹174,885.0 Cr -0.5% 8.9% 10.8% Stock Analytics
CIPLA ₹127,930.0 Cr 0.4% 3.7% 8% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,108.0 Cr -0% -2.1% 6.6% Stock Analytics
DR REDDYS LABORATORIES ₹107,164.0 Cr 2.2% -1.8% -4.4% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-7.7%

37.5%

87.9%

SENSEX

0.9%

2.5%

3.7%


You may also like the below Video Courses